Come to think of it I dont recall any bio trial result being a proper success recently...
Either they fail and report bad outcomes or they report 'successful outcomes' but market doesnt care for a myriad of reasons some specific to the company itself.
Think there's a general sentiment of fear and de-risking perhaps.